Non-stented Ureteroscopic Laser Lithotripsy for Ureteric Stones Clinical Trial
Official title:
Effect of Perioperative Selective alpha1-blockers in Non-stented Ureteroscopic Laser Lithotripsy for Ureteric Stones
To assess the efficacy of peri-operative alpha1 blockers on improving the success rate and decreasing complications of non-stented ureteroscopic laser lithotripsy for ureteric stones.
Objective: To assess the efficacy of peri-operative alpha1 blockers on improving the success
rate and decreasing complications of non-stented ureteroscopic laser lithotripsy for ureteric
stones.
Patients and Methods: A randomized control trial was conducted at two high volume urological
centers from September 2017 to December 2018. We enrolled 120 patients with lower ureteric
stones. They were randomly divided into two groups. Group A had 58 patients who underwent
non-stented ureteroscopy using Ho-YAG laser for stone disintegration and received
alpha1-blockers for one week preoperatively and another two weeks postoperatively, while
Group B had 62 patients who underwent non-stented ureteroscopy and laser and received
placebo.
;